Research
Hormonal
Incretin-based therapies were associated with a mean reduction in the apnea-hypopnea index (AHI) of -14.45 events/h.
Incretin-based therapies may effectively reduce AHI in OSA patients, improving sleep quality.
StrongSupportsmedium confidence
Incretin-based therapies were also associated with AHI reduction, with a mean change of -14.45 events/h (95 % CI: 25.90 to -2.99, p < 0.001).
Why this rating
Derived from a systematic review and meta-analysis of randomized controlled trials.
Source
Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials
Anna Bardóczi et al. · Sleep Medicine Reviews · 2025
Meta-analysisCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →